Entera Bio
ENTX
3 hedge funds and large institutions have $3.99M invested in Entera Bio in 2019 Q4 according to their latest regulatory filings, with funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 2 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 1
52% more capital invested
Capital invested by funds: $2.62M → $3.99M (+$1.37M)
7.01% more ownership
Funds ownership: 8.8% → 15.81% (+7%)
40% less funds holding
Funds holding: 5 → 3 (-2)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
KCM
Knoll Capital Management
Miami,
Florida
|
+$2.9M |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$355 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DAM
DLD Asset Management
New York
|
-$919K |
| 2 |
WVP
Worth Venture Partners
Fort Lee,
New Jersey
|
-$39K |
| 3 |
WCM
Wildcat Capital Management
New York
|
-$31.3K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
KCM
1
Knoll Capital Management
Miami,
Florida
| $3.6M | +$2.9M | +1,265,823 | +266% |
|
|
WCM
2
Wildcat Capital Management
New York
| $384K | -$31.3K | -13,664 | -7% |
|
|
3
UBS Group
Zurich,
Switzerland
| $1K | +$355 | +155 | +33% |
|
|
DAM
4
DLD Asset Management
New York
| – | -$919K | -369,000 | Closed |
|
|
WVP
5
Worth Venture Partners
Fort Lee,
New Jersey
| – | -$39K | -16,454 | Closed |
|
ENTX Hedge Fund Activity: Q4 2019 in Review
3 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Entera Bio (ENTX) for Q4 2019, worth a combined $3.99M — up 52% from $2.62M a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of ENTX and 0 opened new positions — a net loss of 2 holders — while 1 trimmed existing stakes and 2 added.
The largest buyer was Knoll Capital Management, adding an estimated $2.9M. The largest seller was DLD Asset Management, exiting entirely with an estimated $919K sold.
- 3 institutional investors held Entera Bio (ENTX) as of Q4 2019, down from 5 in Q3 2019.
- Funds reported $3.99M of Entera Bio stock for Q4 2019, up 52% quarter-over-quarter.
- 0 funds opened new Entera Bio positions in Q4 2019 and 2 closed out, a net change of -2 holders.
- The largest Entera Bio buyer in Q4 2019 was Knoll Capital Management, an estimated $2.9M added.
- The largest Entera Bio seller in Q4 2019 was DLD Asset Management, an estimated $919K sold.
Based on aggregated 13F filings for Q4 2019.